Atlas Trials

Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT06447636 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06447636
Sponsor
Fudan University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerGastro Esophageal Junction Cancer
Start date
2024-09-30
Primary completion
2026-05-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.